Pharmacor is one of the newest entities on the Australian pharmaceutical market. Would you please introduce the company to let Pharmaceutical Executive readers understand more about…
In Conversation
Would you please introduce the PBAC and the role it plays in Australia’s pharmaceutical sector? The Pharmaceutical Benefits Advisory Committee (PBAC) is a statutory committee of…
Molteni was created in 1892 and progressively developed a strong manufacturing base, a very active R&D department and a growing international presence. Could you introduce the…
To begin, would you please introduce Medicines Australia to Pharmaceutical Executive readers? Medicines Australia is the association that represents the country’s research-based pharmaceutical industry. With approximately…
Mr. Ammelburg of Roche described Thailand as a very difficult and different market and according to PReMA figures there was only 2 percent growth last year.…
TPMA is the main association bringing together the local manufacturers in Thailand. What do you consider to have been the main milestones and achievements since your…
PReMa was established in 2004 after a period of transformation to represent the growing role of its members, research-based companies. To begin with, could you explain…
For decades now, ACG has been building up its reputation in the global pharma space. The Indian Pharma industry, at the same time, increasingly is catching…
For decades now, ACG has been building up its reputation in the global pharma space. The Indian Pharma industry, at the same time, increasingly is catching…
You already joined the company in 2001, and returned after an MBA in the USA in 2004. This was also the time the company really took…
Watson is one the largest generic players in the US but the international presence of the company is still relatively modest. Watson does not have commercial…
“ The managing director of Encube Ethicals discusses contract manufacturing in India today, growing competition from China, and partnering with the world's leading multinational pharma companies. ”
